Dell (DELL) and Intel (INTC) Backing iAbra’s Virolens “20 Second” COVID-19 Test
US media hasn’t picked up on the linkage to DELL and INTC. The potential of a 20 second COVID-19 test is “priceless”. The existence of this test allows governments to loosen social distancing restrictions as they get used at schools, universities, airports, hospitals, sporting events...the list is endless!
The One Factor That May Distinguish Can-Fite BioPharma (CANF)
This is a play on the treatment of Covid-19 rather than a preventative vaccine Before the pandemic, one of the flagship drugs under the Can-Fite pipeline was Piclidenoson. An orally administered drug, Piclidenoson is essentially a small-molecule inhibitor that targets enzymes that cause inflammation.
Your Step-by-Step Guide to Investing in Australian Stocks
It’s a big world out there. While investors should maintain their core holdings in strong, U.S.-based companies with reasonable growth and earnings...
Small-Cap Gold and Silver Stocks to Buy to Profit from the Crisis
Due to the unprecedented crisis that is the novel coronavirus pandemic, investors are scrambling for the best sector in which to protect...
Could COVID-19 Concerns Be Helping To Drive Sales of Glucose Health’s (OTC Pink: GLUC)...
As more information becomes available pertaining to the Coronavirus pandemic and the association with certain pre-existing medical conditions, health experts are growing...
5 Pandemic Stocks to Buy That Are Off the Beaten Path
With the dramatic changes inherent in the novel coronavirus pandemic, it was no surprise that virtually all investment sectors tumbled in the...
CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street
It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is...
Xalles Holdings Inc. (XALL) Growing Through Synergistic Acquisitions
Xalles Holdings (OTC: XALL), a financial technology holdings company, led by CEO Thomas Nash, has been the poster child for future CEO’s to...
STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)
The feline has attacked CytoDyn Inc. (OTCMKTS: CYDY) nine times within the last 8 months in an...
LOMIKO METALS (LMRMF), (LMR) ENGAGES KENMAR SECURITIES AS EXCLUSIVE ADVISOR TO RAISE $ 40...
Miami, FL – July 20, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...
Latest News
Healthcare to reduce the cost of medical – It’s not just...
Marble Arch Research notes that PetVivo (OTCQB: PETV)achieved a major funding milestone last month, removing the main obstacle to its product commercialization goals. Commercial production of its disruptive osteoarthritis treatment device, Kush®, for canines and equines, a market we estimate is worth ~$3BN in the US alone, is due to commence in September 2020.
